Compare Exelixis (EX9) vs. Competitors

3 Followers

Comparison Results

EX9

Exelixis

―

CHF12.15B

18.31

3 Buy

9 Hold

1 Sell

Hold

Incyte

$128.12

$22.85B

13.95

32.06%

11 Buy

10 Hold

0 Sell

Moderate Buy

Jazz Pharmaceuticals

$260.23

$14.44B

14.48

61.45%

18 Buy

1 Hold

0 Sell

Strong Buy

Summit Therapeutics

$14.23

$13.73B

-15.46

-26.44%

10 Buy

6 Hold

0 Sell

Moderate Buy

Zai Lab

$26.82

$2.78B

-14.07

-26.36%

3 Buy

0 Hold

0 Sell

Strong Buy

Genmab

$34.36

$21.10B

28.62

10.11%

9 Buy

1 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

EX9 vs GMAB

xxxxxxxxxxxxx

Performance Comparison

CH:EX9

Exelixis

―

INCY

Incyte

112.75

28.95

34.55%

JAZZ

Jazz Pharmaceuticals

222.45

87.02

64.25%

SMMT

Summit Therapeutics

17.17

-4.18

-19.58%

ZLAB

Zai Lab

24.81

-5.43

-17.96%

GMAB

Genmab

36.05

4.24

13.33%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >